Medgenics Director Andrew Pearlman Sells 20,000 Shares (MDGN)
Medgenics (NASDAQ:MDGN) Director Andrew Pearlman sold 20,000 shares of Medgenics stock on the open market in a transaction dated Tuesday, February 4th. The shares were sold at an average price of $8.00, for a total value of $160,000.00. Following the completion of the transaction, the director now directly owns 40,562 shares in the company, valued at approximately $324,496. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Medgenics (NASDAQ:MDGN) traded up 2.44% during mid-day trading on Thursday, hitting $8.40. The stock had a trading volume of 87,329 shares. Medgenics has a 1-year low of $3.50 and a 1-year high of $8.54. The stock’s 50-day moving average is $6.7 and its 200-day moving average is $6.00. The company’s market cap is $154.6 million.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.